Hospital admissions caused by adverse drug events: an Australian prospective study
Alexandra L. Phillips A B , Olimpia Nigro C , Karen A. Macolino C , Kirsty C. Scarborough C , Christopher J. Doecke C D F , Manya T. Angley E and Sepehr Shakib CA Noarlunga Health Service, Alexander Kelly Drive, Noarlunga Centre, SA 5168, Australia.
B School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia. Email: alexandra.phillips@health.sa.gov.au
C Royal Adelaide Hospital, Adelaide, SA 5000, Australia. Email: olimpia.nigro@health.sa.gov.au; karen.macolino@health.sa.gov.au; kirsty.scarborough@health.sa.gov.au; sepehr.shakib@health.sa.gov.au
D School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia.
E Sansom Institute for Health Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA 5000, Australia. Email: manya.angley@unisa.edu.au
F Corresponding author. Email: chris.doecke@health.sa.gov.au
Australian Health Review 38(1) 51-57 https://doi.org/10.1071/AH12027
Submitted: 3 December 2012 Accepted: 8 October 2013 Published: 19 December 2013
Abstract
Objective To assess the frequency of adverse drug event (ADE)-related admissions (ADE-RAs) during a prospective medical record review of patients admitted to a metropolitan tertiary referral hospital.
Methods Potential ADE-RA cases were identified by examination of case records of randomly selected patients. Cases were assessed by an expert panel to measure study outcomes, which were the frequency (ADEs and ADE-RAs) as well as type, likelihood of causality, severity, avoidability and detection of ADEs.
Results Of the 370 subjects, 59 (16.0%) had a confirmed ADE-RA, with 15 (4.1%) of these serious and preventable. The 59 ADE-RAs were a result of 72 discreet ADEs. Adverse drug reactions were the most common type of ADE, followed by non-compliance. Of the 72 discreet ADEs, 31.9% were classified as ‘probable’ or ‘highly probable’. Most ADEs (54.2%) were classified as ‘definitely avoidable’, 34.7% were classified as ‘severe’ and 21.8% were classified as both ‘definitely avoidable’ and ‘severe’. Half the ADEs were detected after the patient had been admitted and most were detected by medical practitioners. Antineoplastics followed by antidiabetic agents were most frequently implicated.
Conclusions Implementing a systems approach that involves multiple strategies, such as improving tertiary-to-primary care information transfer and promoting medication adherence through education programs, is necessary to tackle the problem of avoidable ADE-RAs and the associated cost burden.
What is known about the topic? It is estimated that 2–3% of Australian hospital admissions are due to adverse drug events (ADEs), but recent data are lacking. According to the Australian Statistics on Medicines, over 250 million prescriptions were dispensed in 2007, compared with just under 180 million in 1997. This 40% increase in drug utilisation over the 10 years surpasses the Australian population growth of 14% in the same period. An increase in drug use per person indicates that the rate of ADEs and possible ADE-related admissions (ADE-RAs) is likely to have increased.
What does this paper add? This prospective study was conducted at a large Australian metropolitan teaching hospital and we report that 59 of 370 participants (16.0%) presenting to the Emergency Department had a confirmed ADE-RA, with 15 (4.1%) presenting with a serious and preventable ADE-RA.
What are the implications for practitioners? The findings of this study support implementing a systems approach involving multiple strategies to tackle the problem of avoidable ADE-RAs and the associated cost burden. This study reveals that half the ADEs were not detected until after the admission process, which reinforces the importance of focusing efforts towards preventing ADE-RAs and detecting ADE-RAs through measures such as those recommended in the Australian Pharmaceutical Advisory Council guiding principles.
References
[1] American Society of Health-System Pharmacists Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm 1998; 55 165–6.| 9465983PubMed |
[2] Miller GC, Britt HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006; 184 321–4.
| 16584364PubMed |
[3] Roughead EE, Lexchin J. Adverse drug events: counting is not enough, action is needed. Med J Aust 2006; 184 315–6.
| 16584361PubMed |
[4] Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008. Aust New Zealand Health Policy 2009; 6 18
| Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002–2008.Crossref | GoogleScholarGoogle Scholar | 19671158PubMed |
[5] Galbraith KJ. Is there a role for a clinical pharmacist in the emergency department? Melbourne: Victorian College of Pharmacy; 1993.
[6] Dartnell JGA, Anderson RP, Chohan V, Galbraith KJ, Lyon MEH, Nestor PJ, et al Hospitalisation for adverse events related to drug therapy: incidence, avoidability and costs. Med J Aust 1996; 164 659–62.
| 1:STN:280:DyaK283lslejsA%3D%3D&md5=3a438b3a482148c3673cef17b2eb9838CAS |
[7] Easton K, Morgan T, Williamson M. Medication safety in the community: a review of the literature. Sydney: National Prescribing Service Limited; 2009.
[8] Capuano A, Motola G, Russo F, Avolio A, Filippelli A, Rossi F, Mazzeo F. Adverse drug events in two emergency departments in Naples, Italy: an observational study. Pharmacol Res 2004; 50 631–6.
| Adverse drug events in two emergency departments in Naples, Italy: an observational study.Crossref | GoogleScholarGoogle Scholar | 15501703PubMed |
[9] Chan M, Nicklason F, Vial J. Adverse drug events as a cause of hospital admission in the elderly. Int Med J 2001; 31 199–205.
| Adverse drug events as a cause of hospital admission in the elderly.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MvgsFGmtw%3D%3D&md5=855df5fca88f145ddfd106db733b21cbCAS |
[10] Jha AK, Kuperman GJ, Rittenberg E, Teich JM, Bates DW. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001; 10 113–19.
| Identifying hospital admissions due to adverse drug events using a computer-based monitor.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3Mvltlaltg%3D%3D&md5=8103ee9767c15e9dc5fb9c3e912e1260CAS | 11499849PubMed |
[11] Major S, Badr S, Bahlawan L, Hassan G, Khogaoghlanian T, Khalil R, Melhem A, Richani R, Younes F, Yeretzian J, Khogali M, Sabra R. Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to self-medicating behavior. Clin Pharmacol Ther 1998; 64 450–61.
| Drug-related hospitalization at a tertiary teaching center in Lebanon: incidence, associations, and relation to self-medicating behavior.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M%2FhsVGgtA%3D%3D&md5=37e8d8acb9aee911d9f57aa1eae9ee5fCAS | 9797802PubMed |
[12] Malhotra S, Karan RS, Pandhi P, Jain S. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77 703–7.
| Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD3MrntVWitg%3D%3D&md5=cd2b489672070b1481e4b6d8ab3efc56CAS | 11677279PubMed |
[13] Raschetti R, Morgutti M, Menniti-Ippolito F, Belisari A, Rossignoli A, Longhini P, et al Suspected adverse drug events requiring emergency department visits or hospital admissions. Eur J Clin Pharmacol 1999; 54 959–63.
| Suspected adverse drug events requiring emergency department visits or hospital admissions.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M3gs12ktA%3D%3D&md5=0c368f3c5d9cbe15b06a3a6ed9c0d7d4CAS | 10192758PubMed |
[14] Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002; 58 285–91.
| Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study.Crossref | GoogleScholarGoogle Scholar | 12136375PubMed |
[15] Trifirò G, Calogero G, Ippolito FM, Cosentino M, Giuliani R, Conforti A, et al Adverse drug events in emergency department population: a prospective Italian study. Pharmacoepidemiol Drug Saf 2005; 14 333–40.
| Adverse drug events in emergency department population: a prospective Italian study.Crossref | GoogleScholarGoogle Scholar | 15682429PubMed |
[16] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30 239–45.
| A method for estimating the probability of adverse drug reactions.Crossref | GoogleScholarGoogle Scholar | 1:CAS:528:DyaL3MXltVygsLk%3D&md5=ac251813c543aa41ce131d213214cf76CAS | 7249508PubMed |
[17] Karch FE, Lasagna L. Adverse drug reactions. A critical review. JAMA 1975; 234 1236–41.
| Adverse drug reactions. A critical review.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaE28%2Fnt1ehug%3D%3D&md5=f9d2172039ba666da09f6eb401a43ac2CAS | 1242749PubMed |
[18] Department of Health and Ageing. Australian statistics on medicines 1997. Canberra: Commonwealth of Australia; 1998.
[19] Department of Health and Ageing. Australian statistics on medicines 2007. Canberra: Commonwealth of Australia; 2009.
[20] Australian Bureau of Statistics. Population by age and sex, Australian states and territories: June 1997 to 2002. Catalogue no. 3201.0. Canberra: Australian Bureau of Statistics; 2003.
[21] Australian Bureau of Statistics. Population, Australian states and territories, December 2007. Catalogue no. 3239.0.55.001. Canberra: Australian Bureau of Statistics; 2008.
[22] Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care 2003; 15 i49–59.
| Adverse drug events and medication errors in Australia.Crossref | GoogleScholarGoogle Scholar | 14660523PubMed |
[23] WHO Collaborating Centre for Drug Statistics Methodology. Anatomical therapeutic chemical index. Available at http://www.whocc.no/atc_ddd_index/ [verified September 2012]
[24] Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47 533–43.
| 1:STN:280:DyaK3c7ps1Sgsw%3D%3D&md5=971e77a985104410cd820c5af818418bCAS | 2316538PubMed |
[25] Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. Ann Pharmacother 1990; 24 1093–7.
| 1:STN:280:DyaK3M7ht1Wluw%3D%3D&md5=fe23bce6f756639a443e197c671ae468CAS |
[26] Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health 1982; 5 58–67.
| Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaL383htFWitQ%3D%3D&md5=ee81f115695d424ec10af6cd895ce5e2CAS | 10278126PubMed |
[27] Australian Institute of Health and Welfare (AIHW). Australian hospital statistics 2007–08. Health services series no. 33. Catalogue no. HSE 71. Canberra: AIHW; 2009. Available at http://www.aihw.gov.au/publications/index.cfm/title/10776 [verified September 2012]
[28] Bond CA, Raehl CL. Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals. Pharmacotherapy 2006; 26 735–47.
| Clinical pharmacy services, pharmacy staffing, and adverse drug reactions in United States hospitals.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DC%2BD283ovVOhuw%3D%3D&md5=78023d9cc6733ec1712d0c7b5347d8d7CAS | 16716127PubMed |
[29] Australian Pharmaceutical Advisory Council. Guiding principles to achieve continuity in medication management. Canberra: Commonwealth of Australia; 2005.
[30] Einarson TR. Drug-related hospital admissions. Ann Pharmacother 1993; 27 832–40.
| 1:STN:280:DyaK3sznt1Cnsw%3D%3D&md5=880d01fc50a2ad5a1b1167089592311bCAS | 8364259PubMed |
[31] Malpass A, Helps SC, Runciman WB. An analysis of Australian adverse drug events. J Qual Clin Pract 1999; 19 27–30.
| An analysis of Australian adverse drug events.Crossref | GoogleScholarGoogle Scholar | 1:STN:280:DyaK1M7psVertw%3D%3D&md5=c42c5b8b65aba4e9097a6bcecb1f5db6CAS | 10096721PubMed |
